London 2014 Registration Visa Letters Programme Satellite Meetings Glaucoma Day 2014 Exhibition Hotel Booking Virtual Exhibition Star Alliance
london escrs

Course handouts are now available
Click here


Come to London

video-icon

WATCH to find out why


Site updates:

Programme Updates. Programme Overview and - Video Symposium on Challenging Cases now available.


The effect of bevacizumab in the treatment of corneal neovascularization: new analysis method

Search Abstracts by author or title
(results will display both Free Papers & Poster)

Session Details

Session Title: Cornea Surgical II

Session Date/Time: Tuesday 16/09/2014 | 08:00-10:30

Paper Time: 09:58

Venue: Boulevard B

First Author: : J.Hwang SOUTH KOREA

Co Author(s): :    M. Park   M. Kim           

Abstract Details

Purpose:

To evaluate the short term effects of bevacizumab injections on the regression of corneal neovascularization and to introduce the new analysis method for corneal neovascularization

Setting:

Prospective/St. Mary's Hospital Seoul, Korea

Methods:

20 patients with corneal NV were injection with 0.05 mg of bevacizumab through subconjunctival. The patients were prospectively followed-up for one month and 3 months after the injections. Corneal NV areas, as shown on corneal slit-lamp photographs stored in JPEG format, were calculated using Image J software and use the color spectrum softeare before the injection, one week after the injection, and one month, 3 months after the injection. The two analysis methods were compared before and after the injections.

Results:

The mean decrease in corneal NV area one and three months after injection were not significant. And Color spectrum method showed higher reproducibility than Image J method

Conclusions:

The mean decrease in corneal NV area one and three months after injection were not significant. And Color spectrum method showed higher reproducibility than Image J method

Financial Interest:

NONE

Back to previous